Heba Bakri/Linkedin
Jul 10, 2025, 16:11
Heba Bakri: Honored to Welcome Assiut University Heamtology Team for a Discussion on Multiple Myeloma Management
Heba Bakri, Consultant of Clinical Oncology at Assiut University, shared a post on LinkedIn:
“It was an honor to welcome Dr. Raffat Abdelfattah and the Haematology team from Assiut University for a rich and insightful discussion on the management of multiple myeloma in the era of anti-CD38 therapy, particularly Daratumumab.
The exchange of experiences across departments and the spirit of collaboration remain essential to advancing patient care.
I had the pleasure of presenting: Practical tips for the use of Daratumumab from pharmacodynamics and kinetics perspectives”
More posts featuring Heba Bakri.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 14:26
Jul 27, 2025, 14:04
Jul 27, 2025, 13:56
Jul 27, 2025, 13:48
Jul 27, 2025, 13:42
Jul 27, 2025, 13:03
Jul 27, 2025, 07:35